Shandong Pharmaceutical Glass: Approved by State-owned Assets to issue up to 199 million A shares to specific targets.

Shandong Pharmaceutical Glass announced that on June 18th, the company received a reply from the State-Owned Assets Supervision and Administration Commission of the People's Government of Zibo regarding the issuance of shares to specific entities by Shandong Pharmaceutical Glass Co., Ltd., agreeing in principle to the company's issuance of no more than 199,084,233 A-shares to specific entities. The proposed private placement still requires approval from the competent state-owned asset supervision and administration department, approval from the company's shareholders' meeting, examination by the Shanghai Stock Exchange, and registration approval from the China Securities Regulatory Commission before implementation. The final outcome is uncertain.